肝静脉压力梯度在慢性肝脏疾病评估中的应用

杜超; 蒋明德

doi:10.3969/j.issn.1001-5256.2014.07.009

肝静脉压力梯度在慢性肝脏疾病评估中的应用

DOI: 10.3969/j.issn.1001-5256.2014.07.009

杜超,
蒋明德

成都军区总医院消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3253
- HTML全文浏览量: 21
- PDF下载量: 648
- 被引次数: 0
出版历程
- 收稿日期: 2014-01-28
- 出版日期: 2014-07-20

Application of HVPG in assessment of chronic liver diseases

Department of Gastroenterology, General Hospital, Chengdu Military Command

摘要

摘要: 慢性肝病评估体系的建立和完善对于临床诊疗具有指导意义,肝静脉压力梯度(HVPG)在慢性肝病进展过程中有着重要意义,是目前唯一独立于病因学之外指导治疗的病理生理学指标。简述了慢性肝病现有的评估手段,对HVPG在慢性肝病评估中的应用作了系统描述,包括HVPG在预测肝硬化程度、门静脉高压静脉曲张出血风险及结局、肝硬化腹水的产生、降低门静脉高压药物以及抗病毒药物疗效和肝癌术后结局等方面的应用。认为HVPG测量对于慢性肝病的疾病进展与预后具有重要的评估作用,是一种能够预测慢性肝病转归的有效指标。
- 肝静脉压力梯度 /
- 肝疾病 /
- 高血压,门静脉 /
- 综述
Abstract: The establishment and perfection of the assessment system for chronic liver diseases have a guiding significance for clinical diagnosis and treatment. Hepatic venous pressure gradient (HVPG) is of great significance in the progression of chronic liver diseases, and it is the only pathophysiological index for treatment independent of etiology. The current methods for evaluation of chronic liver diseases are simply described, and the application of HVPG in evaluation of chronic liver diseases is systematically summarized, including predicting the severity of liver cirrhosis, variceal bleeding risk and outcome of portal hypertension, development of cirrhotic ascites, efficacy of drugs for reducing portal hypertension and antiviral drugs, and postoperative outcome of liver cancer. It is thought that HVPG measurement plays an important role in the assessment of the progression and prognosis of chronic liver diseases and is an effective predictor of outcome.
- hepatic venous pressure gradient /
- liver diseases /
- hypertension, portal /
- review

HTML全文

参考文献(29)

[1]FRIEDMAN SL.Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury[J].J Biol Chem, 2000, 275 (4) :2247-2250.

[2]PINZANI M, ROMANELLI RG, MAGLI S.Progression of fibrosis in chronic liver diseases:time to tally the score[J].J Hepatol, 2001, 34 (5) :764-767.

[3]HALL A, GERMANI G, ISGRG, et al.Fibrosis distribution in explanted cirrhotic livers[J].Histopathology, 2012, 60 (2) :270-277.

[4]KROOK H.Estimation of portal venous pressure by occlusive hepatic vein catheterization[J].Scand J Clin Lab Invest, 1953, 5 (3) :285-292.

[5]BOSCH J, GARCIA-PAGAN JC, BERZIGOTTI A, et al.Measurement of portal pressure and its role in the management of chronic liver disease[J].Semin Liver Dis, 2006, 26 (4) :348-362.

[6]QI XL, WANG L.Method for measuring portal pressure and its progress[J].J Chin Pract Diag Ther, 2012, 26 (12) :1145-1147. (in Chinese) 祁小龙, 王蕾.门静脉压力测定方法及进展[J].中华实用诊断与治疗杂志, 2012, 26 (12) :1145-1147.

[7]ALBILLLOS A, GARCIA-TSAO G.Classification of cirrhosis:the clinical use of HVPG measurements[J].Dis Markers, 2011, 31 (3) :121-128.

[8]KUMAR M, KUMAR A, HISSAR S, et al.Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus[J].Liver Int, 2008, 28 (5) :690-698.

[9]RINCON D, Lo LACONO O, TEJEDOR M, et al.Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis[J].Scand J Gastroenterol, 2013, 48 (4) :487-495.

[10]BLASCO A, FORNS X, CARRIN JA, et al.Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation[J].Hepatology, 2006, 43 (3) :492-499.

[11]SUK KT, KIM HC, NAMKUNG S, et al.Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B[J].Eur J Gastroenterol Hepatol, 2013, 25 (10) :1170-1176.

[12]GROSZMANN RJ, GARCIA-TSAO G, BOSCH J, et al.Beta blockers to prevent gastroesophageal varices in patients with cirrhosis[J].N Engl J Med, 2005, 353 (21) :2254-2261.

[13]KUMAR A, SHARMA P, SARIN SK.Hepatic venous pressure gradient measurement:time to learn![J].Indian J Gastroenterol, 2008, 27 (2) :74-80.

[14]ADDLEY J, THAM TC, CASH WJ.Use of portal pressure studies in the management of variceal haemorrhage[J].World J Gastrointest Endosc, 2012, 4 (7) :281-289.

[15]MOITINHO E, ESCORSELL A, BANDI JC, et al.Prognostic value of early measurements of portal pressure in acute variceal bleeding[J].Gastroenterology, 1999, 117 (3) :626-631.

[16]ABRALDES JG, VILLANUEVA C, BAARES R, et al.Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy[J].J Hepatol, 2008, 48 (2) :229-236.

[17]MONESCILLO A, MARTINEZ-LAGARES F, RUIZ-ARBOL L, et al.Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding[J].Hepatology, 2004, 40 (4) :793-801.

[18]DITTRICH S, MATTOS AA, MATTOS AZ, et al.Relationship between portal pressure gradient and ascites in cirrhotic patients[J].Arq Gastroenterol, 2010, 47 (2) :174-177.

[19]KIM MY, BAIK SK, SUK KT, et al.Measurement of hepatic venous pressure gradient in liver cirrhosis:relationship with the status of cirrhosis, varices, and ascites in Korea[J].Korean J Hepatol, 2008, 14 (2) :150-158.

[20]GULZAR GM, ZARGAR A, JALAL S, et al.Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver[J].Indian J Gastroenterol, 2009, 28 (2) :59-61.

[21]MERKEL C, BOLOGNESI M, SACERDOTI D, et al.The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis[J].Hepatology, 2000, 32 (5) :930-934.

[22]ALBILLOS A, BANARES R, GONZALEZ M, et al.Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension:a meta-analysis[J].Am J Gastroenterol, 2007, 102 (5) :1116-1126.

[23]La MURA V, ABRALDES JG, RAFFA S, et al.Prognostic value of acute hemodynamic response to i.v.propranolol in patients with cirrhosis and portal hypertension[J].J Hepatol, 2009, 51 (2) :279-287.

[24]RINCON D, RIPOLL C, Lo IACONO O, et al.Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis[J].Am J Gastroenterol, 2006, 101 (10) :2269-2274.

[25]ROBERTS S, GORDON A, MCLEAN C, et al.Effect of sustainedviral response on hepatic venous pressure gradient in hepatitis Crelated cirrhosis[J].Clin Gastroenterol Hepatol, 2007, 5 (8) :932-937.

[26]BURROUGHS AK, GROSZMANN R, BOSCH J, et al.Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C:is hepatic venous pressure gradient a better end point?[J].Gut, 2002, 50 (3) :425-427.

[27]BRUIX J, CASTELLS A, BOSCH J, et al.Surgical resection of hepatocellular carcinoma in cirrhotic patients:prognostic value of preoperative portal pressure[J].Gastroenterology, 1996, 111 (4) :1018-1102.

[28]HIDAKA M, TAKATSUKI M, SOYAMA A, et al.Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma[J].Br J Surg, 2012, 99 (9) :1284-1289.

[29]KIM MY, BAIK SK, YEA CJ, et al.Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis[J].Eur J Gastroenterol Hepatol, 2009, 21 (11) :1241-1246.

施引文献

资源附件(0)

访问统计